The Eyes on Washington Podcast – Details, episodes & analysis

Public Policy & Regulation attorney Liz Craddock, Senior Public Affairs Advisor Isabel Lane and Senior Policy Advisor Peter Tabor break down the impacts of the new One Big Beautiful Bill Act on the food and agriculture industries in this episode of "The Eyes on Washington" podcast series. They highlight how the legislation affects renewable energy and biofuels, including a rollback of several clean energy tax credits established under the Inflation Reduction Act (IRA). The conversation also covers changes to the Supplemental Nutrition Assistance Program (SNAP), updates on the Make America Healthy Again movement (MAHA), immigration issues within the agriculture sector, the Farm Bill and the shifting trade and tariff landscape.

In this episode of Holland & Knight's "The Eyes on Washington" podcast series, attorneys Rachel Gartner, Sara Klock, John Vaughan and Michael Werner discuss the evolving landscape of U.S. Food and Drug Administration (FDA) regulation throughout the early months of the Trump Administration. Key topics include the significant organizational changes at the FDA, ongoing legal battles over compounded GLP-1 drugs and their market access, regulatory uncertainties surrounding laboratory-developed tests (LDTs) and anticipated reforms in food ingredient safety and cosmetic product oversight. The conversation also explores the administration's shifting approach to the regulation of artificial intelligence (AI) in healthcare, predicting a lighter federal touch with increased state-level involvement and industry self-regulation. Additionally, the episode touches on the status of cannabis regulation and the fluid nature of enforcement and policy amid changes in the federal government, offering listeners valuable insights into navigating the current FDA regulatory environment.

In this insightful episode of our "Eyes on Washington" election mini-series, Holland & Knight Partners Elizabeth "Liz" Craddock and Jim Noe explore what a potential Harris Administration could mean for the oil and gas industry. Drawing from their extensive experience in energy policy and the oil and gas sector, Ms. Craddock and Mr. Noe discuss Vice President Kamala Harris's evolving stance on energy issues and how it might shape future policies. They also examine the potential continuation or expansion of Biden Administration policies, regulatory challenges and the role of environmental regulations in shaping the industry's future.

This podcast was taped in late August and some issues have updates since then but on a whole the podcast lays out relevant issues for next Administration.

In this episode of "The Eyes on Washington Podcast," Public Policy & Regulation attorneys Michael Werner, Sara Klock, Joshua Odintz and Ed Perlmutter discuss the proposed rule by the U.S. Drug Enforcement Administration (DEA) to movie marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act. They explore how the reclassification could impact federal and state regulation, U.S. tax policy, banking rules and product approvals. The discussion also highlights the need for stakeholders to carefully engage with these evolving regulatory changes.

This episode was originally released on June 4, 2024 | In this episode of "The Eyes on Washington Podcast," Public Policy & Regulation attorney Rich Gold is joined by public policy attorney Dimitrios Karakitsos and former Holland & Knight appellate litigation attorney Amit Agarwal to discuss the U.S. Supreme Court's impending decision related to Chevron deference. Loper Bright Enterprises v. Raimondo and Relentless v. Department of Commerce were consolidated and presented to the high court. Attorneys essentially have asked the justices to revisit its Chevron doctrine, which reviewing courts use to defer to agency interpretations of the statutes they're charged with administering. Mr. Gold, Mr. Agarwal and Mr. Karakitsos weigh the legal and political implications of the Supreme Court's decision ahead of its release.

In the latest episode of Holland & Knight's Public Policy & Regulation Group "Eyes on Washington" podcast series, Healthcare & Life Sciences attorneys Michael Werner and Sara Klock examine pivotal shifts in U.S. Food and Drug Administration (FDA) regulations.

This episode explores updates in three crucial areas: the regulation of laboratory developed tests (LDTs), the proposed reclassifying of cannabis to a Schedule III drug by the U.S. Drug Enforcement Administration (DEA) and the FDA's evolving approach to artificial intelligence (AI). It also covers the FDA's revised guidance on new dietary ingredient notifications (NDINs) for dietary supplements. The discussion provides a comprehensive overview of these significant regulatory updates, breaking down potential impacts and exploring opportunities for industry engagement in influencing upcoming changes.

In this episode of our Eyes on Washington Podcast Special Miniseries about the National Defense Authorization Act (NDAA), national security attorney Dan Sennott sits down with corporate and securities attorney David Cole and public policy attorney Paul Stimers. Their discussion centers around general themes in the fiscal year 2024 (FY 2024) NDAA related to emerging technology.

In this episode of our Eyes on Washington Podcast Special Miniseries about the National Defense Authorization Act (NDAA), National Security attorney Dan Sennott is joined by Government Contracts attorney Eric Crusius. Their conversation focuses on cybersecurity provisions in the FY24 NDAA and what those provisions may indicate about future Department of Defense (DoD) priorities, regulations and policies.

This Eyes on Washington Podcast Special Miniseries breaks down the National Defense Authorization Act (NDAA), which is the yearly authorization of funding and policy for the entire Department of Defense (DoD). Hosted by attorney Dan Sennott, this miniseries delves deep into the Fiscal Year 2024 (FY24) NDAA, its wide-reaching provisions, policy initiatives and the associated laws being passed in Congress. In each episode of this miniseries, Holland & Knight attorneys will tackle specific topics and themes in the FY24 NDAA.

This episode was originally released on September 28, 2023 | In this episode of Holland & Knight Public Policy & Regulation Group's "Eyes on Washington" podcast series, Senior Policy Advisor Lauren Maddox sits down with Andy Rotherham, co-founder and partner at Bellwether Education Partners, a national nonprofit organization working to support educational innovation. Their conversation takes a deep dive into the rises and pitfalls taking place in the education space today. Topics discussed include how the U.S. can improve its education system, the long-term effects of the COVID-19 pandemic on learning and school systems, and the use of artificial intelligence in the classroom. Mr. Rotherham shares final thoughts on the challenges and changes being faced in education to wrap up the conversation.

This episode was originally released on September 25, 2023 | In this episode of the "Eyes on Washington" podcast series by Holland & Knight's Public Policy & Regulation Group, Healthcare and Life Sciences attorneys Michael Werner and Sara Klock discuss recent developments in marijuana, particularly federal legislation and the regulation of cannabis products in the United States. This conversation focuses on the possible rescheduling of marijuana from a Schedule I drug to a Schedule III drug, as recommended by the U.S. Department of Health and Human Services (HHS), and the impact that change could have on the industry at large, especially in states where marijuana use is already legal. While the timeline isn’t explicit, Mr. Werner and Ms. Klock emphasize that the regulatory environment is likely to undergo a number of changes in the next couple years and beyond. They also explain how the rescheduling process works and which regulatory bodies and federal agencies play a major role. The discussion concludes with insightful recommendations for industry stakeholders, including growers, distributors, state governments and researchers.